The invention relates to compounds of formula I,
wherein the substituents are as defined in the specification; to processes for the preparation of such compounds; pharmaceutical compositions comprising such compounds; such compounds as a medicament; such compounds for the treatment of a proliferative disease.
申请人:GlaxoSmithKline Intellectual Property Development Limited
公开号:US10364256B2
公开(公告)日:2019-07-30
The present invention relates to biaryl pyrazole compounds of Formula (I)
methods of making them, pharmaceutical compositions containing them and their use as NRF2 regulators.
申请人:GlaxoSmithKline Intellectual Property Development Limited
公开号:US20180282349A1
公开(公告)日:2018-10-04
The present invention relates to biaryl pyrazole compounds of Formula (I)
methods of making them, pharmaceutical compositions containing them and their use as NRF2 regulators.